Search

Walter E. Webb

Examiner (ID: 5438, Phone: (571)270-3287 , Office: P/1612 )

Most Active Art Unit
1612
Art Unit(s)
1612, 4133
Total Applications
1277
Issued Applications
576
Pending Applications
113
Abandoned Applications
605

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7168507 [patent_doc_number] => 20050202049 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Retinoid-containing preparations' [patent_app_type] => utility [patent_app_number] => 10/515636 [patent_app_country] => US [patent_app_date] => 2003-07-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3946 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202049.pdf [firstpage_image] =>[orig_patent_app_number] => 10515636 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/515636
Retinoid-containing preparations Jul 15, 2003 Abandoned
Array ( [id] => 5040257 [patent_doc_number] => 20070092539 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Method of preparing an aqueous meloxicam solution and aqueous solution thus produced' [patent_app_type] => utility [patent_app_number] => 10/564271 [patent_app_country] => US [patent_app_date] => 2003-07-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 1763 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092539.pdf [firstpage_image] =>[orig_patent_app_number] => 10564271 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/564271
Method of preparing an aqueous meloxicam solution and aqueous solution thus produced Jul 9, 2003 Abandoned
Array ( [id] => 5743670 [patent_doc_number] => 20060089395 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Nf-kb activation inhibitors' [patent_app_type] => utility [patent_app_number] => 10/516294 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 70632 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0089/20060089395.pdf [firstpage_image] =>[orig_patent_app_number] => 10516294 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/516294
Nf-kb activation inhibitors Jun 4, 2003 Abandoned
Array ( [id] => 5632332 [patent_doc_number] => 20060148802 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Use of compounds that stimulate cgmp' [patent_app_type] => utility [patent_app_number] => 10/516778 [patent_app_country] => US [patent_app_date] => 2003-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3691 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148802.pdf [firstpage_image] =>[orig_patent_app_number] => 10516778 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/516778
Use of compounds that stimulate cgmp May 29, 2003 Abandoned
Array ( [id] => 5851764 [patent_doc_number] => 20060234955 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-10-19 [patent_title] => 'Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders' [patent_app_type] => utility [patent_app_number] => 10/515260 [patent_app_country] => US [patent_app_date] => 2003-05-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 12910 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0234/20060234955.pdf [firstpage_image] =>[orig_patent_app_number] => 10515260 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/515260
Cardiac glycosides to treat cystic fibrosis and other il-8 dependent disorders May 27, 2003 Abandoned
Array ( [id] => 5648496 [patent_doc_number] => 20060134228 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-22 [patent_title] => 'Medicine for prevention of and treatment for amyloidosis' [patent_app_type] => utility [patent_app_number] => 10/514335 [patent_app_country] => US [patent_app_date] => 2003-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 3958 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20060134228.pdf [firstpage_image] =>[orig_patent_app_number] => 10514335 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/514335
Medicine for prevention of and treatment for amyloidosis May 12, 2003 Abandoned
Array ( [id] => 5808309 [patent_doc_number] => 20060094664 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-04 [patent_title] => 'Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation' [patent_app_type] => utility [patent_app_number] => 10/512856 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3191 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0094/20060094664.pdf [firstpage_image] =>[orig_patent_app_number] => 10512856 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/512856
Deoxycholic acid derivatives for the treatment of acute dysfunctions of portal and hepatic venous circulation May 8, 2003 Abandoned
Array ( [id] => 7193586 [patent_doc_number] => 20050163853 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Novel biomaterials their preparation and use' [patent_app_type] => utility [patent_app_number] => 10/511075 [patent_app_country] => US [patent_app_date] => 2003-04-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12606 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163853.pdf [firstpage_image] =>[orig_patent_app_number] => 10511075 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/511075
Novel biomaterials their preparation and use Apr 16, 2003 Abandoned
Array ( [id] => 5715192 [patent_doc_number] => 20060078555 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-13 [patent_title] => 'Intraventricular hemorrhage thrombolysis' [patent_app_type] => utility [patent_app_number] => 10/509694 [patent_app_country] => US [patent_app_date] => 2003-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17068 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0078/20060078555.pdf [firstpage_image] =>[orig_patent_app_number] => 10509694 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/509694
Intraventricular hemorrhage thrombolysis Mar 28, 2003 Abandoned
Array ( [id] => 7142995 [patent_doc_number] => 20050118269 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'External preparation for wounds' [patent_app_type] => utility [patent_app_number] => 10/507522 [patent_app_country] => US [patent_app_date] => 2003-03-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6143 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0118/20050118269.pdf [firstpage_image] =>[orig_patent_app_number] => 10507522 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/507522
External preparation for wounds Mar 11, 2003 Issued
Array ( [id] => 6911787 [patent_doc_number] => 20050175545 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-08-11 [patent_title] => 'Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist' [patent_app_type] => utility [patent_app_number] => 10/503540 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 17596 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0175/20050175545.pdf [firstpage_image] =>[orig_patent_app_number] => 10503540 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503540
Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist Feb 3, 2003 Abandoned
Array ( [id] => 7111750 [patent_doc_number] => 20050209206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier' [patent_app_type] => utility [patent_app_number] => 10/503000 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10940 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209206.pdf [firstpage_image] =>[orig_patent_app_number] => 10503000 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503000
Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier Feb 3, 2003 Abandoned
Array ( [id] => 239612 [patent_doc_number] => 07592329 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-09-22 [patent_title] => 'Crystalline complexes of fluticasone-2-furoate' [patent_app_type] => utility [patent_app_number] => 10/503114 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 36 [patent_figures_cnt] => 36 [patent_no_of_words] => 23501 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 10 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/592/07592329.pdf [firstpage_image] =>[orig_patent_app_number] => 10503114 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503114
Crystalline complexes of fluticasone-2-furoate Feb 3, 2003 Issued
Array ( [id] => 7200332 [patent_doc_number] => 20050164996 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions' [patent_app_type] => utility [patent_app_number] => 10/502902 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9577 [patent_no_of_claims] => 40 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20050164996.pdf [firstpage_image] =>[orig_patent_app_number] => 10502902 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/502902
Pharmaceutical formulation comprising an aqueous suspension of an androstane derivative for the treatment of inflammatory and allergic conditions Feb 3, 2003 Abandoned
Array ( [id] => 5894322 [patent_doc_number] => 20060002861 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-01-05 [patent_title] => 'Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist' [patent_app_type] => utility [patent_app_number] => 10/502966 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 11957 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20060002861.pdf [firstpage_image] =>[orig_patent_app_number] => 10502966 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/502966
Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothiate androstanes with a muscarinic receptor antagonist Feb 3, 2003 Abandoned
Array ( [id] => 6982775 [patent_doc_number] => 20050152845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-14 [patent_title] => 'Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form' [patent_app_type] => utility [patent_app_number] => 10/503394 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 12737 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20050152845.pdf [firstpage_image] =>[orig_patent_app_number] => 10503394 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503394
Amorphous fluticasone 2-furoate, pharmaceutical compositions thereof and its conversion to the crystalline unsolvated form Feb 3, 2003 Abandoned
Array ( [id] => 7098488 [patent_doc_number] => 20050130947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-16 [patent_title] => 'Formulations for inhalation' [patent_app_type] => utility [patent_app_number] => 10/503396 [patent_app_country] => US [patent_app_date] => 2003-02-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 9905 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0130/20050130947.pdf [firstpage_image] =>[orig_patent_app_number] => 10503396 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/503396
Formulations for inhalation Feb 3, 2003 Abandoned
Array ( [id] => 7020088 [patent_doc_number] => 20050222107 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Novel process' [patent_app_type] => utility [patent_app_number] => 10/502866 [patent_app_country] => US [patent_app_date] => 2003-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8949 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0222/20050222107.pdf [firstpage_image] =>[orig_patent_app_number] => 10502866 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/502866
Novel process Feb 2, 2003 Abandoned
Array ( [id] => 7256710 [patent_doc_number] => 20050143388 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Nitric oxide donors for treatment of disease and injury' [patent_app_type] => utility [patent_app_number] => 10/500694 [patent_app_country] => US [patent_app_date] => 2003-01-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 18515 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143388.pdf [firstpage_image] =>[orig_patent_app_number] => 10500694 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/500694
Nitric oxide donors for treatment of disease and injury Jan 5, 2003 Abandoned
Array ( [id] => 5700630 [patent_doc_number] => 20060217315 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method' [patent_app_type] => utility [patent_app_number] => 10/499505 [patent_app_country] => US [patent_app_date] => 2002-12-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6510 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217315.pdf [firstpage_image] =>[orig_patent_app_number] => 10499505 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/499505
Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method Dec 19, 2002 Abandoned
Menu